(Q35100284)

6 August 2017

1 reference

title

Breast cancer management: quality-of-life and cost considerations (English)

1 reference

6 August 2017

1 reference

2

Alberto Redaelli

1 reference

6 August 2017

Davide Radice

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

383-396

1 reference

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group

6 August 2017

cites work

1 reference

12 December 2020

Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis

1 reference

12 December 2020

A chronic disease score from automated pharmacy data

1 reference

12 December 2020

Aromatase inhibitors and inactivators for breast cancer therapy

1 reference

12 December 2020

Chemoprevention of breast cancer: recommendations and rationale

1 reference

12 December 2020

Chemoprevention with aromatase inhibitors--trial strategies

1 reference

12 December 2020

Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study

1 reference

12 December 2020

Economic costs of neoplasms, arteriosclerosis, and diabetes in the United States

1 reference

12 December 2020

Adjuvant trials of aromatase inhibitors: determining the future landscape of adjuvant endocrine therapy

1 reference

12 December 2020

Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization.

1 reference

12 December 2020

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

1 reference

12 December 2020

Cancer treatment and age: patient perspectives

1 reference

12 December 2020

Emotional responses to the diagnosis of cancer: age-related comparisons

1 reference

12 December 2020

Upstaging tamoxifen? New classes of drugs emerging for breast cancer

1 reference

12 December 2020

Quality of life in breast cancer patients: measurement issues in cancer clinical trials

1 reference

12 December 2020

Quality of life index for patients with cancer

1 reference

12 December 2020

ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics

1 reference

12 December 2020

Estimates of the lifetime costs of breast cancer treatment in Canada.

1 reference

12 December 2020

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

12 December 2020

A summary of second-line randomized studies of aromatase inhibitors

1 reference

12 December 2020

Age differences in the psychosocial problems encountered by breast cancer patients.

1 reference

12 December 2020

The prognostic value of quality-of-life scores: preliminary results of an analysis of patients with breast cancer.

1 reference

12 December 2020

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

1 reference

12 December 2020

Ongoing and planned adjuvant trials with trastuzumab.

1 reference

12 December 2020

Social and Economic Factors in the Choice of Lung Cancer Treatment

1 reference

12 December 2020

Breast cancer survivors: an exploration of quality of life issues.

1 reference

12 December 2020

Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs

1 reference

12 December 2020

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

12 December 2020

Aromatase inhibitors and inactivators in breast cancer

1 reference

12 December 2020

Ten- to fourteen-year effect of screening on breast cancer mortality

1 reference

12 December 2020

Estimates of the lifetime direct costs of treatment for metastatic breast cancer.

1 reference

12 December 2020

The costs of treating breast cancer in the United Kingdom: implications for screening

1 reference

12 December 2020

Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

12 December 2020

Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?

1 reference

12 December 2020

Evaluation of quality of life in patients receiving treatment for advanced breast cancer

1 reference

12 December 2020

Estimating the treatment costs of breast and lung cancer

1 reference

12 December 2020

Underutilization of Breast-Conserving Surgery and Radiation Therapy Among Women With Stage I or II Breast Cancer

1 reference

12 December 2020

Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute

1 reference

12 December 2020

Mammography utilization, public health impact, and cost-effectiveness in the United States

1 reference

12 December 2020

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

1 reference

12 December 2020

Quality of Life after Cytotoxic Chemotherapy: Discussion Paper

1 reference

12 December 2020

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Cancer statistics, 2001

1 reference

12 December 2020

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

12 December 2020

10.2165/00019053-200321060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1047090614

0 references

1 reference